In the past 12 months (February 25, 2025 to February 24, 2026), REGN returned 7.32% versus 17.03% for the S&P 500 (SPY) and 19.02% for Nasdaq 100 (QQQ).
In the past 5 years (February 26, 2021 to February 24, 2026), REGN returned 72.54% versus 93.58% for the S&P 500 (SPY) and 99.39% for Nasdaq 100 (QQQ). $1 invested in REGN in 2021 became $1.73 in 2026.
In the past 10 years (February 29, 2016 to February 24, 2026), REGN had an annualized return of 7.31% versus 15.41% for the S&P 500 (SPY) and 20.38% for Nasdaq 100 (QQQ). $1 invested in REGN in 2016 became $2.02 in 2026.
Since April 2006 (April 10, 2006 to February 24, 2026) REGN had an annualized return of 22.20% versus 10.76% for the S&P 500 (SPY) and 15.23% for Nasdaq 100 (QQQ). $1 invested in REGN in 2006 became $53.96 in 2026.
Ticker
Company Name
Total Returns
$1 turns into
Annualized Returns
Annualized Volatility
Sharpe Ratio
REGN
Regeneron Pharmaceuticals, Inc.
5296.16%
$53.96
22.20%
42.69%
0.52
SPY
SPDR S&P 500 ETF Trust
664.15%
$7.64
10.76%
19.44%
0.55
QQQ
Invesco QQQ Trust, Series 1
1575.96%
$16.76
15.23%
22.02%
0.69
Returns adjusted for splits and dividends.
Period start date is the earliest common trading day in the selected time period across all tickers.